Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial Meeting Abstract
| Authors: | Powles, T. B.; Escudier, B.; de Souza, P.; Chowdhury, S.; Pook, D.; Harmenberg, U.; Basappa, N.; Geynisman, D.; Merchan, J.; Redman, B. G.; Ryan, C.; Goodman, O.; Ho, T.; Singh, P.; Lougheed, J.; Patel, M.; Knox, J. J.; Motzer, R. J.; Choueiri, T. K. |
| Abstract Title: | Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi284 |
| Language: | English |
| ACCESSION: | WOS:000393912500809 |
| DOI: | 10.1093/annonc/mdw373.41 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 814P -- Source: Wos |
